FDA approves at-home use of FluMist nasal spray vaccine
The FDA has approved the at-home use of AstraZeneca's FluMist nasal spray vaccine. A prescription will still be required.
- Maine's Changing Climate
- 2024 Election
- Maine Things To Do
- Lewiston Strong
- Let's Talk About It
- Myler Makes It
- PFAS
- Tick Talk
- Coats and Toys for Kids
- Varsity Club
- VERIFY
- Gardening with Gutner
- Advertise With Us
- Closings and Delays
- Feed Maine
- Gift Shop
- NCM Jobs
- Project Heat
- Meet The Team
- Dempsey Challenge
- Closing Registration